ARTICLE | Company News

J&J neurology news

March 31, 2014 7:00 AM UTC

The Arkansas Supreme Court reversed and remanded a 2012 lower court ruling, which fined Johnson & Johnson $1.2 billion for violating state fraud statues through promotional practices of its antipsychotic Risperdal risperidone. The Supreme Court found that the Pulaski County Circuit Court incorrectly applied state law that governs healthcare facilities, which J&J is "indisputably not." ...